Development
Healwell AI Inc.
AIDX.TO
TSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -13.22% | -23.30% | -6.96% | -8.06% | -76.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.22% | -23.30% | -6.96% | -8.06% | -76.43% |
| Cost of Revenue | -2.64% | -17.58% | -6.85% | -6.70% | -77.41% |
| Gross Profit | -37.87% | -35.94% | -7.24% | -10.51% | -73.79% |
| SG&A Expenses | 30.76% | 22.77% | -18.36% | -33.62% | -56.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.14% | -16.10% | -11.90% | -8.48% | -58.04% |
| Operating Income | -12.17% | 9.22% | 15.47% | 9.43% | 14.40% |
| Income Before Tax | -42.41% | -165.05% | -46.63% | 26.99% | 6.32% |
| Income Tax Expenses | -106.04% | 45.17% | 76.80% | -304.31% | 10,697.24% |
| Earnings from Continuing Operations | 16.70% | -247.78% | -72.22% | 33.90% | -56.58% |
| Earnings from Discontinued Operations | 33.97% | 221.72% | 27.38% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -172.91% | -83.29% | 119.82% | 22.61% | 6,037.50% |
| Net Income | 16.13% | -124.52% | -61.23% | 33.56% | -60.44% |
| EBIT | -12.17% | 9.22% | 15.47% | 9.43% | 14.40% |
| EBITDA | -30.49% | 14.69% | -6.26% | 8.92% | 7.15% |
| EPS Basic | 22.05% | -108.46% | -55.59% | 34.17% | -58.78% |
| Normalized Basic EPS | -12.08% | 8.56% | 18.93% | 10.84% | 13.87% |
| EPS Diluted | 22.05% | -108.46% | -55.59% | 34.17% | -58.78% |
| Normalized Diluted EPS | -12.08% | 8.56% | 18.93% | 10.84% | 13.87% |
| Average Basic Shares Outstanding | 7.58% | 7.58% | 3.70% | 0.89% | 1.08% |
| Average Diluted Shares Outstanding | 7.58% | 7.58% | 3.70% | 0.89% | 1.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |